AAAAAA

   
Results: 1-12 |
Results: 12
ANALYSIS OF LOSS OF HETEROZYGOSITY AND KRAS2 MUTATIONS IN OVARIAN NEOPLASMS - CLINICOPATHOLOGICAL CORRELATIONS
Authors: CHENEVIXTRENCH G KERR J HURST T SHIH YC PURDIE D BERGMAN L FRIEDLANDER M SANDERSON B ZOURNAZI A COOMBS T LEARY JA CRAWFORD E SHELLING AN COOKE I GANESAN TS SEARLE J CHOI C BARRETT JC KHOO SK WARD B
Citation: G. Chenevixtrench et al., ANALYSIS OF LOSS OF HETEROZYGOSITY AND KRAS2 MUTATIONS IN OVARIAN NEOPLASMS - CLINICOPATHOLOGICAL CORRELATIONS, Genes, chromosomes & cancer, 18(2), 1997, pp. 75-83
ROLE OF P53 IN DRUG-RESISTANCE IN OVARIAN-CANCER
Authors: SHELLING AN
Citation: An. Shelling, ROLE OF P53 IN DRUG-RESISTANCE IN OVARIAN-CANCER, Lancet, 349(9054), 1997, pp. 744-745
ALLELE LOSS ON CHROMOSOME ARM 6Q AND FINE MAPPING OF THE REGION AT 6Q27 IN EPITHELIAL OVARIAN-CANCER
Authors: COOKE IE SHELLING AN LEMEUTH VG CHARNOCK FML GANESAN TS
Citation: Ie. Cooke et al., ALLELE LOSS ON CHROMOSOME ARM 6Q AND FINE MAPPING OF THE REGION AT 6Q27 IN EPITHELIAL OVARIAN-CANCER, Genes, chromosomes & cancer, 15(4), 1996, pp. 223-233
AN INTEGRATED GENETIC-MAP OF CHROMOSOME-6
Authors: COOKE IE COX SA SHELLING AN LEMEUTH VG SPURR NK GANESAN TS
Citation: Ie. Cooke et al., AN INTEGRATED GENETIC-MAP OF CHROMOSOME-6, Mammalian genome, 7(2), 1996, pp. 157-159
EPITHELIAL OVARIAN-CANCER - FUTURE-PROSPECTS FOR TREATMENT
Authors: SHELLING AN COOKE IE LEMEUTH VG GANESAN TS
Citation: An. Shelling et al., EPITHELIAL OVARIAN-CANCER - FUTURE-PROSPECTS FOR TREATMENT, New Zealand medical journal, 109(1020), 1996, pp. 131-132
AF6 GENE ON CHROMOSOME BAND 6Q27 MAPS DISTAL TO THE MINIMAL REGION OFDELETION IN EPITHELIAL OVARIAN-CANCER
Authors: SAHA V LILLINGTON DM SHELLING AN CHAPLIN T YASPO ML GANESAN TS YOUNG BD
Citation: V. Saha et al., AF6 GENE ON CHROMOSOME BAND 6Q27 MAPS DISTAL TO THE MINIMAL REGION OFDELETION IN EPITHELIAL OVARIAN-CANCER, Genes, chromosomes & cancer, 14(3), 1995, pp. 220-222
LOCALIZATION OF AN EPITHELIAL-SPECIFIC RECEPTOR KINASE (EDDR1) TO CHROMOSOME 6Q16
Authors: SHELLING AN BUTLER R JONES T LAVAL S BOYLE JM GANESAN TS
Citation: An. Shelling et al., LOCALIZATION OF AN EPITHELIAL-SPECIFIC RECEPTOR KINASE (EDDR1) TO CHROMOSOME 6Q16, Genomics, 25(2), 1995, pp. 584-587
OVARIAN-CANCER IN NEW-ZEALAND POLYNESIANS
Authors: SHELLING AN
Citation: An. Shelling, OVARIAN-CANCER IN NEW-ZEALAND POLYNESIANS, New Zealand medical journal, 108(993), 1995, pp. 45-45
THE GENETIC-ANALYSIS OF OVARIAN-CANCER
Authors: SHELLING AN COOKE IE GANESAN TS
Citation: An. Shelling et al., THE GENETIC-ANALYSIS OF OVARIAN-CANCER, British Journal of Cancer, 72(3), 1995, pp. 521-527
ISOLATION AND CHARACTERIZATION OF AN EPITHELIAL-SPECIFIC RECEPTOR TYROSINE KINASE FROM AN OVARIAN-CANCER CELL-LINE
Authors: LAVAL S BUTLER R SHELLING AN HANBY AM POULSOM R GANESAN TS
Citation: S. Laval et al., ISOLATION AND CHARACTERIZATION OF AN EPITHELIAL-SPECIFIC RECEPTOR TYROSINE KINASE FROM AN OVARIAN-CANCER CELL-LINE, Cell growth & differentiation, 5(11), 1994, pp. 1173-1183
TARGETED INTEGRATION OF TRANSFECTED AND INFECTED ADENOASSOCIATED VIRUS VECTORS CONTAINING THE NEOMYCIN RESISTANCE GENE
Authors: SHELLING AN SMITH MG
Citation: An. Shelling et Mg. Smith, TARGETED INTEGRATION OF TRANSFECTED AND INFECTED ADENOASSOCIATED VIRUS VECTORS CONTAINING THE NEOMYCIN RESISTANCE GENE, Gene therapy, 1(3), 1994, pp. 165-169
FLUORESCENCE IN-SITU HYBRIDIZATION ANALYSIS USING COSMID PROBES TO DEFINE CHROMOSOME 6Q ABNORMALITIES IN OVARIAN-CARCINOMA CELL-LINES
Authors: LASTOWSKA MA LILLINGTON DM SHELLING AN COOKE I GIBBONS B YOUNG BD GANESAN TS
Citation: Ma. Lastowska et al., FLUORESCENCE IN-SITU HYBRIDIZATION ANALYSIS USING COSMID PROBES TO DEFINE CHROMOSOME 6Q ABNORMALITIES IN OVARIAN-CARCINOMA CELL-LINES, Cancer genetics and cytogenetics, 77(2), 1994, pp. 99-105
Risultati: 1-12 |